0001161697-17-000492.txt : 20171113
0001161697-17-000492.hdr.sgml : 20171110
20171113162057
ACCESSION NUMBER: 0001161697-17-000492
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171109
FILED AS OF DATE: 20171113
DATE AS OF CHANGE: 20171113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tierney David S
CENTRAL INDEX KEY: 0001292636
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 171196168
MAIL ADDRESS:
STREET 1: C/O ABLE LABORATORIES, INC.
STREET 2: 6 HOLLYWOOD COURT, CN 1013
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 1250
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 1250
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 11-09-2017
X0306
4
2017-11-09
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001292636
Tierney David S
355 ALHAMBRA CIRCLE, SUITE 1250
CORAL GABLES
FL
33134
1
0
0
0
Common stock, par value $0.001 per share
2017-11-09
4
M
0
50000
0.47
A
313401
D
Common stock, par value $0.001 per share
2017-11-09
4
F
0
7860
D
305541
D
Options to purchase common stock
0.47
2017-11-09
4
M
0
50000
0
D
2012-12-12
2017-12-12
Common Stock
50000
145000
D
Holder exercised 50,000 options at $0.47 per share via cashless exercise and was issued 42,140 shares based on the November 8, 2017 closing price of $2.99 per share.
/s/ David S. Tierney
2017-11-09